We are conscious of the responsibility we share for present and future generations and see sustainable action as a prerequisite for long-term business success. We are focused on creating long-term value and weigh our actions in terms of their impact on the environment, society, patients and employees.
Introduction
Sharon Curran, Member of the Supervisory Board, is introducing MorphoSys’ 2022 Non-Financial Group Report. She highlights the key points from the report addressing environmental, social and governance topics: ensuring patient access to our medicines; spotlight on our people, our most important asset and making our world more sustainable.
Read More